<code id='49E461C783'></code><style id='49E461C783'></style>
    • <acronym id='49E461C783'></acronym>
      <center id='49E461C783'><center id='49E461C783'><tfoot id='49E461C783'></tfoot></center><abbr id='49E461C783'><dir id='49E461C783'><tfoot id='49E461C783'></tfoot><noframes id='49E461C783'>

    • <optgroup id='49E461C783'><strike id='49E461C783'><sup id='49E461C783'></sup></strike><code id='49E461C783'></code></optgroup>
        1. <b id='49E461C783'><label id='49E461C783'><select id='49E461C783'><dt id='49E461C783'><span id='49E461C783'></span></dt></select></label></b><u id='49E461C783'></u>
          <i id='49E461C783'><strike id='49E461C783'><tt id='49E461C783'><pre id='49E461C783'></pre></tt></strike></i>

          hotspot

          hotspot

          author:entertainment    Page View:7768
          A device component from Paradromics Inc., one of the main brain-computer interface players racing to get to market. Courtesy Paradromics Inc.

          Rodney Gorham loves fast, flashy cars: His WhatsApp profile picture is a bright yellow Corvette Stingray. “I don’t get to drive it anymore,” Gorham told STAT in a text.

          Gorham, a 63-year-old living in Australia, has amyotrophic lateral sclerosis. He can’t speak, and can move his hands and legs only a little. But he is able to control his computer with his thoughts, aided by a brain-computer interface developed by the startup Synchron. 

          advertisement

          “It has been exciting to be involved,” Gorham wrote. 

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Medical records are filled with copy
          Medical records are filled with copy

          AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

          read more
          Apple Vision Pro: A first look at health apps on the new VR headset
          Apple Vision Pro: A first look at health apps on the new VR headset

          CourtesyXaia/Cedars-SinaiAppleVisionPro,thecompany’smostimportantnewproductinadecade,promisestoenvel

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

          RogelioV.Solis/APWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechne